Related Experiment Video
Updated: Jul 2, 2026

Precision Implementation of Minimal Erythema Dose (MED) Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
[Application of the medicine profile in an ambulatory setting]
Lene Ørskov Reuther1, Søren Bidstrup List, Hanne Rolighed Christensen
1Bispebjerg Hospital, Klinisk Farmakologisk Enhed, København NV. lenereuther@hotmail.com
Introduction:
A person with a digital signature can access his or her own personal electronic medicinal profile (PEM) which can also be accessed by the person's prescribing doctors. The PEM provides an overview and contains an overview of the prescription medicine sold to the patient over the previous two years.
Materials And Methods:
Randomly-selected geriatric ambulatory patients were included. Accordance between physicians' medication records and the PEM was calculated. Moreover, the prescribing ambulatory doctor and the patient's general practitioner were asked if the PEM could contribute with non-recognized information about patients' prescription medicine.
Results:
We found a 13-20% discrepancy between physicians' medication records and PEMs, involving 50-60% of the patients. In most cases, access to the PEM significantly corrected the discrepancies. Discrepancies were neither correlated to gender, age nor to the amount of prescription medicine. Discrepancies were judged to be serious or influential.
Conclusion:
The PEM provides insight into unrecognized information about patients' prescription medicine and access to the PEM bridges the gap between primary and secondary health care. Easier access to the digital signature, inclusion of over-the-counter drugs, and improved protection against misuse would further improve the PEM and ensure access to updated drug information.
Related Concept Videos
Dosage Regimens: Partial Pharmacokinetic Parameters
Measurement of Bioavailability: Pharmacodynamic Methods
Documentation in Long-Term and Home Healthcare Setting
Long-Term Care Facilities
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...